FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Chia-Chi Lin

Research Profile

Procedures

Chemicals & Drugs

Disorders

Concepts & Ideas

Co-author Network

Publications

TOP 3
Bin-Chi Liao; Chia-Chi Lin; James Chih-Hsin Yang
First-Line Management of EGFR-Mutated Advanced Lung Adenocarcinoma: Recent Developments.
Chia-Chi Lin; Jann-Yuan Wang; Yeong-Shiau Pu
Active tuberculosis during temsirolimus and bevacizumab treatment.
Feng-Ming Hsu; Pei-Ming Huang; Jang-Ming Lee; Yung-Chie Lee; Chia-Chi Lin; Yu-Chieh Tsai; Chih-Hung Hsu; Jason Chia-Hsien Cheng
Retrospective analysis of outcome differences in preoperative concurrent chemoradiation with or without elective nodal irradiation for esophageal squamous cell carcinoma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Chia-Chi Lin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Bin-Chi Liao; Chia-Chi Lin; James Chih-Hsin Yang
First-Line Management of EGFR-Mutated Advanced Lung Adenocarcinoma: Recent Developments.
Drugs 2013;73(4):357-69.
2013: Chia-Chi Lin; Jann-Yuan Wang; Yeong-Shiau Pu
Active tuberculosis during temsirolimus and bevacizumab treatment.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(2):e18-20.
2011: Feng-Ming Hsu; Pei-Ming Huang; Jang-Ming Lee; Yung-Chie Lee; Chia-Chi Lin; Yu-Chieh Tsai; Chih-Hung Hsu; Jason Chia-Hsien Cheng
Retrospective analysis of outcome differences in preoperative concurrent chemoradiation with or without elective nodal irradiation for esophageal squamous cell carcinoma.
International journal of radiation oncology, biology, physics 2011;81(4):e593-9.
2011: Chia-Chi Lin
RET mutations and medullary thyroid cancer.
Journal of the Formosan Medical Association = Taiwan yi zhi 2011;110(11):731; author reply 732.
2011: René H Medema; Chia-Chi Lin; James Chih-Hsin Yang
Polo-like kinase 1 inhibitors and their potential role in anticancer therapy, with a focus on NSCLC.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(20):6459-66.
2011: Jang-Ming Lee; Jin-Shing Chen; Jason Chia-Hsien Cheng; Tzu-Hsuen Chuang; Chih-Hung Hsu; Hsao-Hsun Hsu; Pei-Ming Huang; Shuenn-Wen Kuo; Chia-Chi Lin; Chia-Tung Shun; Ying-Hao Wang; Ming-Tsang Wu; Pei-Wen Yang; Shi-Yi Yang; Yung-Chie Lee
Polymorphism in epidermal growth factor receptor intron 1 predicts prognosis of patients with esophageal cancer after chemoradiation and surgery.
Annals of surgical oncology 2011;18(7):2066-73.
2011: Chia-Chi Lin; James Chih-Hsin Yang
Optimal management of patients with non-small cell lung cancer and epidermal growth factor receptor mutations.
Drugs 2011;71(1):79-88.
2010: Chia-Chi Lin; Hsin-Hsin Hsu; Chia-Tung Sun; Jin-Yuan Shih; Zhong-Zhe Lin; Chong-Jen Yu; George G Chen; Michael Kuan Yew Hsin; Kwok Chi Lam; Linda Leung; Chih-Hsin Yang; Tony Shu Kam Mok
Chemotherapy response in East Asian non-small cell lung cancer patients harboring wild-type or activating mutation of epidermal growth factor receptors.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010;5(9):1424-9.
2010: Yu-Yun Shao; Chia-Chi Lin; Chih-Hsin Yang
Gefitinib or erlotinib in the treatment of advanced non-small cell lung cancer.
Discovery medicine 2010;9(49):538-45.
2010: Hui-Fen Mao; Wan-Yin Chen; Grace Yao; Sheau-Ling Huang; Chia-Chi Lin; Wen-Ni Wennie Huang
Cross-cultural adaptation and validation of the Quebec User Evaluation of Satisfaction with Assistive Technology (QUEST 2.0): the development of the Taiwanese version.
Clinical rehabilitation 2010;24(5):412-21.
2009: Chia-Chi Lin; Chih-Hung Hsu; Jason C Cheng; Chao-Yuan Huang; Yu-Chieh Tsai; Feng-Ming Hsu; Kuo-How Huang; Ann-Lii Cheng; Yeong-Shiau Pu
Induction cisplatin and fluorouracil-based chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer.
International journal of radiation oncology, biology, physics 2009;75(2):442-8.
2009: Feng-Ming Hsu; Yung-Chie Lee; Jang-Ming Lee; Chih-Hung Hsu; Chia-Chi Lin; Yu-Chieh Tsai; Jian-Kuen Wu; Jason Chia-Hsien Cheng
Association of clinical and dosimetric factors with postoperative pulmonary complications in esophageal cancer patients receiving intensity-modulated radiation therapy and concurrent chemotherapy followed by thoracic esophagectomy.
Annals of surgical oncology 2009;16(6):1669-77.
2009: Chia-Chi Lin; Chih-Hsin Yang
Epidermal growth factor receptor tyrosine kinase inhibitors in elderly or poor performance status patients with advanced non-small cell lung cancer.
Targeted oncology 2009;4(1):37-44.
2008: Chiun Hsu; Sow-Hsong Kuo; Fu-Chang Hu; Ann-Lii Cheng; Jin-Yuan Shih; Chong-Jen Yu; Chia-Chi Lin; Tsu-Chen Huang; Pan-Chyr Yang; Chih-Hsin Yang
Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma--a randomized phase II trial.
Lung cancer (Amsterdam, Netherlands) 2008;62(3):334-43.
2008: Chia-Chi Lin; Yeong-Shiau Pu; Chih-Hung Hsu; Hsiao-Yi Keng; Ann-Lii Cheng; Chih-Hsin Yang
Acute encephalopathy following arsenic trioxide for metastatic urothelial carcinoma.
Urologic oncology 2008;26(6):659-61.
2008: Yeong-Shiau Pu; Chuang-Wei Wang; Guang-Yaw Liu; Yi-Zih Kuo; Chao-Yuan Huang; Wang-Yi Kang; Chia-Tung Shun; Chia-Chi Lin; Wen-Jeng Wu; Tzyh-Chyuan Hour
Down-regulated expression of RhoA in human conventional renal cell carcinoma.
Anticancer research 2008;28(4B):2039-43.
2008: Feng-Ming Hsu; Chia-Chi Lin; Jang-Ming Lee; Yih-Leong Chang; Chih-Hung Hsu; Yu-Chieh Tsai; Yung-Chie Lee; Jason Chia-Hsien Cheng
Improved local control by surgery and paclitaxel-based chemoradiation for esophageal squamous cell carcinoma: results of a retrospective non-randomized study.
Journal of surgical oncology 2008;98(1):34-41.
2008: Zhong-Zhe Lin; Chiun Hsu; Yeun-Chung Chang; Chong-Jen Yu; Chih-Hung Hsu; Chia-Chi Lin; Ann-Lii Cheng; Pan-Chyr Yang; Chih-Hsin Yang
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment.
Lung cancer (Amsterdam, Netherlands) 2008;60(2):215-21.
2008: Chia-Chi Lin; Chih-Hung Hsu; Yeong-Shiau Pu; Nicholas J Vogelzang
Systemic therapy for metastatic urothelial carcinoma.
BJU international 2008;101(7):795-803.
2008: Chia-Chi Lin; Hao-Chung Kuo; Peng-Chun Peng; Gong-Ru Lin
Chirp and error rate analyses of an optical-injection gain-switching VCSEL based all-optical NRZ-to-PRZ converter.
Optics express 2008;16(7):4838-47.
2007: Chia-Chi Lin; Kun-Huei Yeh; Chih-Hsin Yang; Chiun Hsu; Yu-Chieh Tsai; Wei-Ling Hsu; Ann-Lii Cheng; Chih-Hung Hsu
Multifractionated paclitaxel and cisplatin combined with 5-fluorouracil and leucovorin in patients with metastatic or recurrent esophageal squamous cell carcinoma.
Anti-cancer drugs 2007;18(6):703-8.
2007: Chia-Chi Lin; Chih-Hung Hsu; Tzyh-Chyuan Hour; Ann-Lii Cheng; Chao-Yuan Huang; Kuo-How Huang; Jun Chen; Yeong-Shiau Pu
Weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in hormone-refractory prostate cancer: in vitro combined effects and a phase II trial.
Urologic oncology 2007;25(3):207-13.
2007: Chia-Chi Lin; Chih-Hung Hsu; Chao-Yuan Huang; Hsiao-Yi Keng; Yu-Chieh Tsai; Kuo-How Huang; Ann-Lii Cheng; Yeong-Shiau Pu
Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: a phase II study.
Anti-cancer drugs 2007;18(4):487-91.
2007: Chia-Chi Lin; Chih-Hung Hsu; Chao-Yuan Huang; Yu-Chieh Tsai; Kuo-How Huang; Ann-Lii Cheng; Yeong-Shiau Pu
Prognostic factors for metastatic urothelial carcinoma treated with cisplatin and 5-fluorouracil-based regimens.
Urology 2007;69(3):479-84.
2007: Chia-Chi Lin; Chiun Hsu; Chih-Hung Hsu; Wei-Ling Hsu; Ann-Lii Cheng; Chih-Hsin Yang
Arsenic trioxide in patients with hepatocellular carcinoma: a phase II trial.
Investigational new drugs 2007;25(1):77-84.
2007: Chia-Chi Lin; Ann-Lii Cheng; Chih-Hung Hsu; Yen-Shen Lu; Chiun Hsu; Kun-Huei Yeh; Chen-Yao Wu; Chiun-Sheng Huang; Chih-Hsin Yang
A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer.
Anticancer research 2007;27(1B):641-5.
2007: Chia-Chi Lin; Chih-Hung Hsu; Chao-Yuan Huang; Ann-Lii Cheng; Nicholas J Vogelzang; Yeong-Shiau Pu
Phase II trial of weekly paclitaxel, cisplatin plus infusional high dose 5-fluorouracil and leucovorin for metastatic urothelial carcinoma.
The Journal of urology 2007;177(1):84-9; discussion 89.
2006: Chia-Chi Lin; Chih-Hung Hsu; Yeong-Shiau Pu
Complete response of urothelial carcinoma to chemotherapy in renal allograft recipients: a two-case study.
Anticancer research 2006;26(4B):3191-5.
2006: Chia-Chi Lin; Chih-Hung Hsu; Chao-Yuan Huang; Ann-Lii Cheng; Jun Chen; Nicholas J Vogelzang; Yeong-Shiau Pu
Weekly cisplatin plus infusional high-dose 5-fluorouracil and leucovorin (P-HDFL) for metastatic urothelial carcinoma: an effective regimen with low toxicity.
Cancer 2006;106(6):1269-75.
2006: Yeong-Shiau Pu; Min-Wei Hsieh; Chuang-Wei Wang; Guang-Yaw Liu; Chao-Yuan Huang; Chia-Chi Lin; Jing-Yi Guan; Shinne-Ren Lin; Tzyh-Chyuan Hour
Epidermal growth factor receptor inhibitor (PD168393) potentiates cytotoxic effects of paclitaxel against androgen-independent prostate cancer cells.
Biochemical pharmacology 2006;71(6):751-60.
2006: Tzyh-Chyuan Hour; Yeong-Shiau Pu; Chia-Chi Lin; Shi-Wei Huang; Jun Chen; Allen W Chiu; Chien-Jen Chen; Chao-Yuan Huang
Differential expression of molecular markers in arsenic- and non-arsenic-related urothelial cancer.
Anticancer research 2006;26(1A):375-8.
2004: Tzyh-Chyuan Hour; Chao-Yuan Huang; Chia-Chi Lin; Jun Chen; Jing-Yi Guan; Jen-Mei Lee; Yeong-Shiau Pu
Characterization of molecular events in a series of bladder urothelial carcinoma cell lines with progressive resistance to arsenic trioxide.
Anti-cancer drugs 2004;15(8):779-85.
2002: Chih-Hung Hsu; Ann-Lii Cheng; Chiun Hsu; Chih-Hsin Yang; Yen-Shen Lu; Chia-Chi Lin; Ching-Fang Bu; Kun-Huei Yeh
A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
Anticancer research 2002;22(6B):3621-7.
2002: Cheng-Chin Ker; Chien-Ching Hung; Shang-Yee Huang; Mao-Yuan Chen; Szu-Min Hsieh; Chia-Chi Lin; Shan-Chwen Chang; Kwen-Tay Luh
Comparison of bone marrow studies with blood culture for etiological diagnosis of disseminated mycobacterial and fungal infection in patients with acquired immunodeficiency syndrome.
Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi 2002;35(2):89-93.